TITLE

health smarts. Synthetic Promise

PUB. DATE
February 2012
SOURCE
PN;Feb2012, Vol. 66 Issue 2, p22
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the result of the study conducted by the researchers at the University of Missouri which reveals that targeting a synthetic molecule to a specific gene could lower the severity of the disease spinal muscular atrophy (SMA). According to researcher Chris Lorson, the mice which received synthetic RNA gain more weight, live longer, and show improvements in motor skills. It notes that SMA is considered the leading genetic cause of infantile mortality in the world.
ACCESSION #
70566234

 

Related Articles

  • Biomarkers in Rare Disorders: The Experience with Spinal Muscular Atrophy. Tiziano, Francesco D.; Neri, Giovanni; Brahe, Christina // International Journal of Molecular Sciences;Jan2011, Vol. 12 Issue 1, p24 

    Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by homozygous mutations of the SMN1 gene. Based on clinical severity, three forms of SMA are recognized (type I-III). All patients have at least one (usually 2-4) copies of a highly homologous gene (SMN2) which...

  • Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy. Swoboda, Kathryn J.; Scott, Charles B.; Reyna, Sandra P.; Prior, Thomas W.; LaSalle, Bernard; Sorenson, Susan L.; Wood, Janine; Acsadi, Gyula; Crawford, Thomas O.; Kissel, John T.; Krosschell, Kristin J.; D'Anjou, Guy; Bromberg, Mark B.; Schroth, Mary K.; Chan, Gary M.; Elsheikh, Bakri; Simard, Louise R. // PLoS ONE;2009, Vol. 4 Issue 5, p1 

    Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit. We performed an open label trial of VPA in 42 subjects with SMA to assess...

  • A mouse model for spinal muscular atrophy. Hsieh-Li, Hsiu Mei; Chang, Jan-Gowth; Jong, Yuh-Jyh; Wu, Mei-Hsiang; Wang, Nancy M.; Tsai, Chang Hai; Li, Hung // Nature Genetics;Jan2000, Vol. 24 Issue 1, p66 

    The survival motor neuron gene is present in humans in a telomeric copy, SMN1, and several centromeric copies, SMN2. Homozygous mutation of SMN1 is associated with proximal spinal muscular atrophy (SMA), a severe motor neuron disease characterized by early childhood onset of progressive muscle...

  • Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy. Taylor, Joanne E; Thomas, Neil H; Lewis, Cathryn M; Abbs, Stephen J; Rodrigues, Nanda R; Davies, Kay E; Mathew, Christopher G // European Journal of Human Genetics;Sep98, Vol. 6 Issue 5, p467 

    Childhood-onset autosomal recessive spinal muscular atrophy (SMA) is associated with absence of the telomeric survival motor neuron gene (SMNt) in most patients, and deletion of the neuronal apoptosis inhibitory protein (NAIP) gene in the majority of severely affected patients. Analysis of SMNt...

  • Differential SMN2 expression associated with SMA severity. Gavrilov, Dimitar K.; Shi, Xiangyang; Das, Kamna; Gilliam, T. Conrad; Wang, Ching H. // Nature Genetics;Nov98, Vol. 20 Issue 3, p230 

    Examines the expression of survival motor neuron gene (SMN) present in patients with spinal muscular atrophy. Presence of SMN in one telomeric copy; Role of SMN2 in the severity of spinal muscular atrophy; Densitometry analysis of SMN transcripts.

  • Characterization of a nuclear 20S complex containing the survival of motor neurons (SMN) protein and a specific subset of spliceosomal Sm proteins. Meister, Gunter // Human Molecular Genetics;Aug2000, Vol. 9 Issue 13, p1977 

    Studies nuclear 20S complex containing the survival of motor neurons protein and a specific subset of spliceosomal Sm proteins. Genetics of spinal muscular atrophy; Mediation of recycling of pre-mRNA splicing factors.

  • Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics. Scharf, Jeremiah M.; Endrizzi, Matthew G.; Wetter, Axel; Huang, Sidong; Thompson, Terri G.; Zerres, Klaus; Dietrich, William F.; Wirth, Brunhilde; Kunkel, Louis M. // Nature Genetics;Sep98, Vol. 20 Issue 1, p83 

    Spinal muscular atrophy (SMA) is a common recessive disorder characterized by the loss of lower motor neurons in the spinal cord. The disease has been classified into three types based on age of onset and severity. SMA I-III all map to chromosome 5q13 (Refs 2,3), and nearly all patients display...

  • Poster presentations: 3. Molecular Genetics.  // Journal of Medical Genetics;Sep2002 Supplement, Vol. 39, pS78 

    Discusses the abstract of the research paper entitled 'Comparison of three methods to determine SMN copy number,' by Rachael Barber, S. McCall et al and presented during the British Human Genetics Conference at the University of York in England in September 2002.

  • SMA carrier testing – validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion. Scheffer, Hans; Cobben, Jan Maarten; Mensink, Rob GJ; Stulp, Rein P; van der Steege, Gerrit; Buys, Charles HCM // European Journal of Human Genetics;Feb2000, Vol. 8 Issue 2, p79 

    To facilitate the detection of carriers of a hemizygous survival motor neuron (SMN) exon 7 deletion we have modified the quantitative SMN exon 7 assay described by McAndrew et al (1997). The major changes include quantitative analysis of the amount of SMN exon 7-specific fluorescently-labelled...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics